company background image
QCIL logo

Quality Chemical Industries UGSE:QCIL Stock Report

Last Price

USh56.00

Market Cap

USh204.5b

7D

1.8%

1Y

6.7%

Updated

21 Nov, 2024

Data

Company Financials

Quality Chemical Industries Limited

UGSE:QCIL Stock Report

Market Cap: USh204.5b

QCIL Stock Overview

A pharmaceutical manufacturing company, produces treatments for HIV/AIDS, Malaria, Hepatitis, and other products in Uganda. More details

QCIL fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends2/6

Quality Chemical Industries Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Quality Chemical Industries
Historical stock prices
Current Share PriceUSh56.00
52 Week HighUSh57.00
52 Week LowUSh52.00
Beta-0.22
11 Month Change1.82%
3 Month Change0%
1 Year Change6.67%
33 Year Change-41.05%
5 Year Change-55.91%
Change since IPO-78.63%

Recent News & Updates

Recent updates

Shareholder Returns

QCILUG PharmaceuticalsUG Market
7D1.8%-1.0%0.2%
1Y6.7%0.8%4.2%

Return vs Industry: QCIL exceeded the UG Pharmaceuticals industry which returned 0.8% over the past year.

Return vs Market: QCIL exceeded the UG Market which returned 4.2% over the past year.

Price Volatility

Is QCIL's price volatile compared to industry and market?
QCIL volatility
QCIL Average Weekly Movement0.7%
Pharmaceuticals Industry Average Movement6.3%
Market Average Movement2.4%
10% most volatile stocks in UG Market2.9%
10% least volatile stocks in UG Market1.0%

Stable Share Price: QCIL has not had significant price volatility in the past 3 months compared to the UG market.

Volatility Over Time: QCIL's weekly volatility (1%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2005362Ajay Palwww.qcil.com

Quality Chemical Industries Limited, a pharmaceutical manufacturing company, produces treatments for HIV/AIDS, Malaria, Hepatitis, and other products in Uganda. It offers antibacterials, anti-hypertensives, vasodilators, anti-emetics, antibiotics, and antidiabetics products; and Lamivudine/Tenofovir Disoproxil Fumarate, Dolutegravir, Efavirenz, and Zidovudine tablets for the treatment of HIV infection. The company also offers Lumartem/Lumet tablets for the treatment of malaria; Texavir and Zentair for the treatment of Hepatitis B; and Isoniazid/Pyridoxine Hydrochloride /Sulfamethoxazole Trimethoprim tablets for the treatment of tuberculosis.

Quality Chemical Industries Limited Fundamentals Summary

How do Quality Chemical Industries's earnings and revenue compare to its market cap?
QCIL fundamental statistics
Market capUSh204.51b
Earnings (TTM)USh50.25b
Revenue (TTM)USh296.39b

4.1x

P/E Ratio

0.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
QCIL income statement (TTM)
RevenueUSh296.39b
Cost of RevenueUSh161.01b
Gross ProfitUSh135.38b
Other ExpensesUSh85.12b
EarningsUSh50.25b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)13.76
Gross Margin45.68%
Net Profit Margin16.96%
Debt/Equity Ratio0%

How did QCIL perform over the long term?

See historical performance and comparison

Dividends

13.6%

Current Dividend Yield

67%

Payout Ratio

Does QCIL pay a reliable dividends?

See QCIL dividend history and benchmarks
When do you need to buy QCIL by to receive an upcoming dividend?
Quality Chemical Industries dividend dates
Ex Dividend DateNov 27 2024
Dividend Pay DateDec 12 2024
Days until Ex dividend5 days
Days until Dividend pay date20 days

Does QCIL pay a reliable dividends?

See QCIL dividend history and benchmarks